EIRGEN PHARMA
EirGen Pharma focuses on the development, registration and commercial manufacture of high potency, high barrier to entry solid dose products for the global pharmaceutical market. EirGen Pharma is fully licensed to manufacture oncology, cytotoxic, steroidal and immunosuppressant molecules in a purpose built high containment facility. The state of the art facilities can also handle the development of moisture sensitive molecules in a low humidity environment. The company has an Investigational Medicinal Products (IMP) licence for the manufacture of clinical trial materials and a Manufacturing Licence for commercial manufacturing and packaging.
EIRGEN PHARMA
Social Links:
Industry:
Health Care Manufacturing Medical Pharmaceutical
Founded:
2005-01-01
Address:
Waterford, Waterford, Ireland
Country:
Ireland
Website Url:
http://www.eirgen.com
Total Employee:
101+
Status:
Active
Contact:
+35351591944
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GStatic Google Static Content
Similar Organizations
GAT Microencapsulation
GAT Microencapsulation specializing in the development, registration and manufacture of advanced plant protection products.
Kutterer Mauer
Kutterer Mauer AG focuses lies on the development & production of high-quality & innovative cap solutions for tubes, bottles, crucibles.
Official Site Inspections
http://www.eirgen.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "EirGen Pharma"
Our Company | Eirgen
Eirgen now serves patients in more than 60 countries worldwide, including major markets such as the USA, Europe, Japan, Canada, Australia, the Middle East and Africa. Our Vision. Improve patient lives. Core Values. Trust. At Eirgen, we …See details»
EirGen Pharma - Crunchbase Company Profile & Funding
EirGen Pharma focuses on the development, registration and commercial manufacture of high potency, high barrier to entry solid dose products for the global pharmaceutical market. EirGen Pharma is fully licensed to manufacture …See details»
Eirgen Pharma - LinkedIn
Eirgen Pharma | 26,578 followers on LinkedIn. End-to-end oral solid dose drug development services for global markets | We are a research-driven company that specialises in the development ...See details»
Eirgen Pharma: Contact Details and Business Profile
Eirgen now serves patients in more than 60 countries worldwide, including major markets such as the USA, Europe, Japan, Canada, Australia, the Middle East and Africa. Nowadays, at Eirgen …See details»
EIRGEN PHARMA LIMITED Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for EIRGEN PHARMA LIMITED of WATERFORD. Get the latest business insights from Dun & Bradstreet.See details»
EirGen Pharma Company Profile - Office Locations, Competitors
EirGen Pharma is a company that produces and supplies various pharmaceutical products. It develops a portfolio of high potency pharma products for both human and veterinary use that …See details»
Eirgen Pharma Ltd - pharmaceutical Technology
At Eirgen Pharma, we simplify the journey of getting your product to market by providing full turnkey CDMO services for the development, manufacture and packaging of high potency oral …See details»
OPKO Health Acquires EirGen Pharma
MIAMI--(BUSINESS WIRE)-- OPKO Health, Inc. (NYSE:OPK) is pleased to announce the acquisition of EirGen Pharma, Ltd., a growing, profitable and cash flow positive specialty pharmaceutical company focused on the development …See details»
EirGen Pharma - Contacts, Employees, Board Members
EirGen Pharma focuses on the development, registration and commercial manufacture of high potency,See details»
co-founder and CEO of EirGen Pharma, Ireland - PharmaBoardroom
Patsy Carney, co-founder and CEO of EirGen Pharma, tells us the strategy behind their 2015 acquisition by US-based OPKO Health, the highlights of their current transformation from an …See details»
Contact | Eirgen
Email: [email protected]. Call Us: +353 51 591 944. Click Here. Have a general enquiry for us? If you have a general enquiry about Eirgen Pharma or our products, simply email, call …See details»
EirGenix, Inc.
“Client's Success is Our Priority” EirGenix upholds the mission of providing clients with high-quality and cost-effective CDMO services and biologics.See details»
US drug company buys EirGen for $135m - The Irish Times
May 6, 2015 Waterford-based pharmaceutical company EirGen has been acquired by US drugs company Opko for $135 million. Founded by Tom Brennan and Patsy Carney 10 years ago, …See details»
EirGen to expand operations in Waterford - Irish Examiner
Apr 5, 2022 EirGen develops and supplies high potency speciality care medicines to patients in over 50 countries. It was established in 2005 and has been part of OPKO Health since 2015.See details»
EirGen Pharma - YouTube
EirGen Pharma is a world-leader in the development, registration, manufacture and supply of high-potency pharmaceutical products to global markets. Based in Waterford, employing over …See details»
Our People - Eirgen
Dan joined Eirgen in 2015 as Supply Chain Manager and became Head of Commercial Operations in December 2019. After more than two successful years of leading Eirgen's …See details»
Multi-million euro investment by EirGen Pharma to create 40 new …
May 9, 2014 EirGen Pharma, the Waterford-based pharmaceutical company, has announced the creation of 40 new jobs at the official opening of its international headquarters today. The …See details»
Process | Eirgen
This adaptability is what sets Eirgen apart, making us a trusted CDMO partner. We get it right the first time. Our industry knowledge and experience has seen Eirgen maintain a blemish-free …See details»
Careers | Eirgen
At Eirgen, we believe that every person who joins our team should have the opportunity to progress and achieve their career goals. As a result, we have countless success stories of …See details»